[1]. Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial.
Brain : a journal of neurology [巻]145 [号]2 [頁]490 -499 （2022年）
[DOI] [2]. Extrastriatal dopamine D2/3 receptor binding, functional connectivity, and autism socio-communicational deficits: a PET and fMRI study.
Molecular psychiatry （2022年） [査読] 有
[DOI] [機関リポジトリ][3]. Serum levels of glial cell line-derived neurotrophic factor as a biomarker for mood disorders and lithium response.
Psychiatry research [巻]301 [頁]113967 （2021年）
[DOI] [4]. Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms.
Molecular autism [巻]12 [号]1 [頁]15 （2021年）
[DOI] [5]. Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorder.
Journal of psychiatric research [巻]134 [頁]48 -56 （2021年）
[DOI]